Aerpio Pharmaceuticals, Inc. announced earnings results for the fourth quarter ended December 31, 2020. For the fourth quarter, the company announced operating loss was USD 5.636 million compared to USD 4.657 million a year ago. Net loss was USD 4.717 million compared to USD 4.446 million a year ago. Basic loss per share from continuing operations was USD 0.1 compared to USD 0.11 a year ago. For the full year, operating loss was USD 6.357 million compared to USD 24.444 million a year ago. Net loss was USD 4.315 million compared to USD 23.271 million a year ago. Basic loss per share from continuing operations was USD 0.1 compared to USD 0.57 a year ago.